Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: Prevalence, intensity of infection, hepatosplenic morbidities and their associated factors
Abstract Background: Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children and does not include neither adult individuals nor other public health measures. The Ijinga schistosomiasis project aims to introduce an intensified treatment protocol using a MDA approach combined with other public health interventions to demonstrate the feasibility of eliminating intestinal schistosomiasis in a highly endemic African setting. In preparation of this project, we report about baseline data on S.mansoni prevalence, intensity of infection, related hepatosplenic morbidities and their associated factors. Methods: A cross sectional study was conducted among 930 individuals aged 3-95 years living at Ijinga Island, north-western Tanzania. Single stool and urine samples were collected from each study participant and processed using Kato Katz (KK) technique and point-of-care Circulating Cathodic (POC-CCA) antigen test for detection of S.mansoni eggs and antigen. Ultrasonographical examination for S.mansoni hepatosplenic morbidities was done to all participants. Results: Overall based on KK technique and POC-CCA test, 68.9% (95%CI: 65.8-71.8) and 94.5% (95%CI: 92.8-95.8) were infected with S.mansoni. The overall geometrical mean eggs per gram (GMepg) of faeces was 85.7epg (95%CI: 77.5-94.8). A total of 27.1%, 31.2% and 51.9% of the study participants had periportal fibrosis (PPF-grade C-F), splenomegaly and hepatomegaly. Risk factors for PPF were being male (aRR=1.08, 95%CI: 1.02-1.16, P<0.01), belong to the age group 16-25 years (aRR=1.23, 95%CI: 105-1.44, P<0.01), 26-35 years (aRR=1.42, 95%CI: 1.21-1.67, P<0.001), 36-45 years (aRR=1.56, 95%CI:1.31-1.84, P<0.001) and ≥ 46 years (aRR=1.64, 95%CI:1.41-1.92, P<0.001). The length of the left liver lobe was associated with being female (P<0.03), belong to the age group 1-5 years (P<0.013), 6-15 years (P<0.04) and S.mansoni intensity of infection (P<0.034). Similarly, being male (aRR=1.15, 95%CI:1.06-1.24, P<0.001), belonging to the age group 16-25 years (aRR=1.27, 95%CI:1.05-1.54, P<0.02), 26-35 years (aRR=1.32, 95%CI:108-1.61, P<0.01) were associated with splenomegaly. Conclusion: Schistosoma mansoni infection and its related morbidities are common in the study area. The prevalence of S.mansoni was above 50% in each age group and based on the observed prevalence, we recommend MDA to the entire community.